GLP1R and kidney disorder: Furthermore, a study examining whether GLP-1 analogs could slow the progression of kidney disease in diabetic patients was prematurely halted due to positive outcomes (Hernandez et al., 2018; Mann et al., 2017; Gerstein et al., 2019).